Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60.
- DOI
- 10.1007/s13555-024-01147-7
- Published
- 2024 Apr
- Container
- Dermatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13555-024-01147-7,
title = {Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60.},
author = {Egeberg A and Hawkes JE and Somani N and Burge R and See K and Gallo G and McKean-Matthews M and Gooderham M and Han G and Armstrong A},
year = {2024},
journal = {Dermatology and therapy},
doi = {10.1007/s13555-024-01147-7},
url = {https://doi.org/10.1007/s13555-024-01147-7}
}RIS
TY - JOUR TI - Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60. AU - Egeberg A AU - Hawkes JE AU - Somani N AU - Burge R AU - See K AU - Gallo G AU - McKean-Matthews M AU - Gooderham M AU - Han G AU - Armstrong A PY - 2024 JO - Dermatology and therapy DO - 10.1007/s13555-024-01147-7 UR - https://doi.org/10.1007/s13555-024-01147-7 ER -
APA
A, E., JE, H., N, S., R, B., K, S., G, G., M, M., M, G., G, H., & A, A. (2024). Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60.. Dermatology and therapy. https://doi.org/10.1007/s13555-024-01147-7
Source records
- pubmed · retrieved 2026-09-27T14:00:28.441Z